Hyphens Pharma

Hyphens Pharma 9M21 PATMI exceeds expectations amidst speed bump in Vietnam: PhillipCapital  - THE EDGE SINGAPORE

Broker's Calls

Hyphens Pharma 9M21 PATMI exceeds expectations amidst speed bump in Vietnam: PhillipCapital

For the 9MFY2021 ended September, Hyphens Pharma reported PATMI of $1.09 million, 28.8% higher y-o-y
Hyphens Pharma gets a 'buy' from SAC as it looks to undertake more R&D initiatives - THE EDGE SINGAPORE

Broker's Calls

Hyphens Pharma gets a 'buy' from SAC as it looks to undertake more R&D initiatives

SAC Capital is maintaining its “buy” call and target price of 37 cents on pharmaceutical distributor Hyphens Pharma.
Broker's Digest: China Aviation Oil, Hyphens Pharma, UG Healthcare, BHG Retail - THE EDGE SINGAPORE

Broker's Calls

Broker's Digest: China Aviation Oil, Hyphens Pharma, UG Healthcare, BHG Retail

See the analysts' recommendations and target prices here.
A promising 1Q2021 performance sees KGI upgrading Hyphens Pharma to 'outperform' - THE EDGE SINGAPORE

Broker's Calls

A promising 1Q2021 performance sees KGI upgrading Hyphens Pharma to 'outperform'

The analysts have upgraded their call on the group from “neutral” to “outperform”, at a revised target price of 43 cents.
PhillipCapital eyes year-end STI at 3,200 - THE EDGE SINGAPORE

Positioning for the recovery

PhillipCapital eyes year-end STI at 3,200

“Investors are positioning ahead of the expected normality to pre-Covid-19 economic conditions," says PhillipCapital.
PhillipCapital cuts Hyphens Pharma's TP on 9M earnings falling below estimates - THE EDGE SINGAPORE

Broker's Calls

PhillipCapital cuts Hyphens Pharma's TP on 9M earnings falling below estimates

Hyphens’ 9MFY2020 earnings came 17% below the analyst's estimates due to other losses arising from inventory obsolescence.

Serial System's chairman Derek Goh loads up after being cleared in Taiwan probe

Derek Goh, executive chairman of Serial Systems, bought 1.5 million shares on the open market for $106,500 on June 2, which works out to an average of 7.1 cents per share. A day earlier and on May 4, Goh had acquired 5.2 million shares for $365,144 and 12

Broker's Calls

Hyphens Pharma weathers Covid-19 storm with increases in all segments

“COVID-19 has created a challenging operating environment, however, we remain agile and to adapt to a different operating environment,” says Hyphens Pharma’s executive chairman & CEO Lim See Wah

Results

Hyphens Pharma 2Q19 earnings up 1.4% to $1.64 mil on lower expenses

Group revenue for the quarter fell 6.1% to $29 million from $30.9 million the preceding year,  due primarily to a decline of 14.1% in the specialty pharma principals segment in 2Q19 on the back of higher demand in 2Q18, ahead of products licensing renewa

Healthcare

Hyphens Pharma launches Magnezix's bioabsorbable metallic implants in Vietnam

SINGAPORE (June 18): Hyphens Pharma has launched in Vietnam the Magnezix brand of implants by Syntellix AG.
×